CD8A and melanoma: CD8+ TRM cells have been identified in various tumour tissues, including melanoma and non-small cell lung cancer, and the density of the cells is associated with improved prognosis and enhanced efficacy of immunotherapies such as checkpoint inhibitors and cancer vaccines [65,66,67,68,69,70].